Search results for "progressive"

showing 10 items of 281 documents

A Comparative Study of General Intelligence in Spanish and Moroccan Samples

2012

The aim of this study is to fill a gap in intelligence research by presenting data for the average IQ in Morocco and for a comparable sample in Spain. Adult samples were administered theRaven Standard Progressive Matrices (SPM)(Raven, Court, & Raven, 2001) and scored for the total test and for the three sub-factors of gestalt continuation, verbal-analytical reasoning and visuospatial ability identified by Lynn, Allik, and Irwing (2004). The total test and the three factors have shown satisfactory reliability. Our results for the Moroccan sample show significant relationship between general intelligence factor, gestalt continuation and visuospatial ability with education level and income…

AdultIntelligence TestsMaleLinguistics and LanguageAdolescentIntelligence quotientIntelligenceSample (statistics)Middle AgedVisuospatial abilityLanguage and LinguisticsTest (assessment)MoroccoRaven's Progressive MatricesSocioeconomic FactorsSpainEducational StatusHumansGestalt psychologyFemalePsychologyGeneral PsychologyAgedClinical psychologyThe Spanish journal of psychology
researchProduct

Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European Intern…

2020

Electrochemotherapy (ECT) is a treatment for both primary and secondary cutaneous tumours. The international Network for sharing practices on ECT group investigates treatment outcomes after ECT using a common database with defined parameters.Twenty-eight centres across Europe prospectively uploaded data over an 11-year period. Response rates were investigated in relation to primary diagnosis, tumour size, choice of electrode type, route of bleomycin administration, electrical parameters recorded and previous irradiation in the treated field.Nine hundred eighty-seven patients, with 2482 tumour lesions were included in analysis. The overall response (OR) rate was 85% (complete response [CR]: …

AdultMale0301 basic medicineCancer ResearchElectrochemotherapySkin NeoplasmsDatabases FactualElectrochemotherapySubgroup analysiscomputer.software_genreYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerHumansMedicineBasal cell carcinomaProspective StudiesKaposi's sarcomaAgedAged 80 and overDatabasebusiness.industryMelanomaMiddle Agedmedicine.disease030104 developmental biologyOncology030220 oncology & carcinogenesisFemaleSarcomabusinesscomputerProgressive diseaseEuropean Journal of Cancer
researchProduct

Cortico-bulbar fibers to orofacial muscles: recordings with enoral surface electrodes.

1997

A new recording technique was developed to eliminate current problems on recording transcranial evoked facial muscle responses. A fork-shaped device equipped with 2 pairs of Ag/AgCl-electrodes was inserted enorally at the buccinator muscle level. Advantages offered by this method comprise clearly defined negative deflection of the compound muscle action potential, lack of relevant volume conduction from adjacent muscles, reliability of amplitude criteria, absence of interfering stimulus artifacts, easy achievement of preactivation, and noninvasive recording by surface electrodes. In 43 healthy subjects transcranial magnetic stimulation evoked contralateral responses at a mean latency and me…

AdultMaleAdolescentmedicine.medical_treatmentFacial ParalysisFacial MusclesElectromyographyMagneticsNerve FibersReference ValuesmedicineHumansElectrodesCerebral CortexMedulla OblongataMouthmedicine.diagnostic_testbusiness.industryGeneral NeuroscienceMusclesAnatomyEquipment DesignMiddle AgedBuccinator muscleFacial nerveElectric StimulationCompound muscle action potentialTranscranial magnetic stimulationFacial musclesElectrophysiologyFacial Nervemedicine.anatomical_structureFemaleNeurology (clinical)Supranuclear Palsy ProgressivebusinessNeuroscienceMotor cortexElectroencephalography and clinical neurophysiology
researchProduct

To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy

2016

OBJECTIVE: To retrospectively analyze the effect of plasma exchange (PLEX; yes = PLEX+ , no = PLEX- ) and steroids administration timing (prophylactically [proST] or therapeutically [therST]) on the longitudinal clinical course of patients with natalizumab-related progressive multifocal leukoencephalopathy (PML) and full-blown immune reconstitution inflammatory syndrome (PML-IRIS). METHODS: Clinical and radiological data of 42 Italian patients with PML were analyzed. Patient's data are available until 12 months after PML diagnosis. PLEX and steroids treatment as time-dependent covariates were entered in: (1) a Cox model to investigate their impact on full-blown PML-IRIS latency; (2) an anal…

AdultMaleAdult; Databases Factual; Disability Evaluation; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Leukoencephalopathy Progressive Multifocal; Male; Plasma Exchange; Retrospective Studies; Steroids; Young Adult; Neurology; Neurology (clinical)Adult; Databases Factual; Disability Evaluation; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Leukoencephalopathy Progressive Multifocal; Male; Plasma Exchange; Retrospective Studies; Steroids; Young AdultDatabases FactualPlasma ExchangeLeukoencephalopathy Progressive MultifocalProgressive MultifocalDatabasesDisability EvaluationYoung AdultNeurologyLeukoencephalopathyImmune Reconstitution Inflammatory SyndromeRetrospective StudieHumansSteroidsFemaleSettore MED/26 - NeurologiaNeurology (clinical)SteroidFactualRetrospective StudiesHuman
researchProduct

Pure Progressive Amnesia and the APPV717G Mutation

2009

We report an isolated, slowly progressive, pure amnestic phenotype in a 59-year-old member of a family affected by autosomal dominant familial Alzheimer disease. Early-onset Alzheimer disease in this family was associated with a V717G mutation in the amyloid precursor protein gene (APP). Subjective impairment of episodic memory began in our subject at the age of 44 years and subsequent, longitudinal neuropsychologic assessment confirmed progressive, severe, global impairment of memory functions over a period of 14 years with preservation of other cognitive domains. The mean annual hippocampal atrophy rate, determined by volumetric magnetic resonance imaging was intermediate between values p…

AdultMaleAgingPathologymedicine.medical_specialtyGlycineAmnesiaHippocampusAmyloid beta-Protein PrecursorAtrophyAlzheimer DiseasemedicineHumansDementiaMemory disorderEpisodic memoryAgedSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCognitive disorderValineMiddle Agedmedicine.diseaseAPPV717G mutation.PedigreePsychiatry and Mental healthClinical PsychologyPhenotypeMutationDisease ProgressionPure progressive amnesiaFemaleAmnesiaAtrophyGeriatrics and Gerontologymedicine.symptomAlzheimer's diseasePsychologyGerontologyFrontotemporal dementia
researchProduct

The effect of age on cognitive performance of frontal patients

2015

Age is known to affect prefrontal brain structure and executive functioning in healthy older adults, patients with neurodegenerative conditions and TBI. Yet, no studies appear to have systematically investigated the effect of age on cognitive performance in patients with focal lesions. We investigated the effect of age on the cognitive performance of a large sample of tumour and stroke patients with focal unilateral, frontal (n=68), or non-frontal lesions (n=45) and healthy controls (n=52). We retrospectively reviewed their cross sectional cognitive and imaging data. In our frontal patients, age significantly predicted the magnitude of their impairment on two executive tests (Raven's Advanc…

AdultMaleAgingRAPM Raven's Advanced Progressive MatricesCognitive NeuroscienceExperimental and Cognitive Psychologybehavioral disciplines and activitiesArticleTBI traumatic brain injuryCVA cerebrovascular accidentExecutive functionsBehavioral NeuroscienceExecutive FunctionPFC prefrontal cortexCognitionArts and Humanities (miscellaneous)WMA white matter abnormalitiesIL Incomplete Letters andAging; Cognitive performance; Executive functions; Frontal lesions non-frontal lesions; Behavioral Neuroscience; Cognitive Neuroscience; Experimental and Cognitive Psychology; Arts and Humanities (miscellaneous)Frontal lesions non-frontal lesionnon-frontal lesionsHumansHC healthy controlsCognitive performanceRetrospective StudiesCWMA Composite White Matter AbnormalitiesFrontal lesionsBrain NeoplasmsGNT Graded Naming TestAge FactorsBrainMiddle AgedFrontal LobeStrokeFrontal lesions non-frontal lesionsIQ Intelligence QuotientStroop TestFemaleNART National Adult Reading TestNeuropsychologia
researchProduct

The role of verbal ability in the processing of complex verbal information.

1994

This study investigated the relation between psychometric mental-ability test scores and several reaction-time measures; a simple-reaction task, a choice-reaction task, the Posner and Mitchell (1967) letter-identification task, and a variation of the sentence-verification task. Scores on the Raven Advanced Progressive Matrices and the Verbal Subtest of the Scholastic Aptitude Test (SATV) were obtained. The less complex information-processing tasks replicate earlier studies in which general intelligence was only marginally related to reaction-time measures. The sentence-verification task systematically varied task complexity. Several direct and derived measures from the task were significant…

AdultMaleAnalysis of VarianceAdolescentPsychological researchIntelligenceInformation processingExperimental and Cognitive PsychologyCognitionGeneral MedicineVerbal LearningVerbal learningbehavioral disciplines and activitiesTest (assessment)Developmental psychologyTask (project management)Raven's Progressive MatricesArts and Humanities (miscellaneous)Developmental and Educational PsychologyReaction TimeHumansFemalePsychologypsychological phenomena and processesSentencePsychological research
researchProduct

Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia.

2000

Idarubicin is the first anthracycline that can be administered orally facilitating antineoplastic chemotherapy at an improved quality of life. In different studies idarubicin has proved clinical effectiveness in patients with advanced low grade non Hodgkin's lymphoma. We performed a phase II study in 19 patients with untreated and pretreated B-CLL of Binet stage A-C. Idarubucin was administered orally at a dose of 15 mg/m2 over 3 days every 4 weeks. Of 19 evaluable patients (m:f, 16:3, median age 64 years, range 41-80 years) 7 were previously untreated while 12 patients had received prior therapy with fludarabine, chlorambucil or similar non-anthracycline containing regimens. 12 pts had Bin…

AdultMaleCancer Researchmedicine.medical_specialtyAnthracyclineNauseaPhases of clinical researchAdministration OralGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineIdarubicinHumans030304 developmental biologyAged0303 health sciencesAntibiotics AntineoplasticChlorambucilbusiness.industryHematologyMiddle Agedmedicine.diseaseLeukemia Lymphocytic Chronic B-Cell3. Good healthSurgeryFludarabineOncology030220 oncology & carcinogenesisVomitingFemalemedicine.symptombusinessIdarubicinProgressive diseasemedicine.drugLeukemialymphoma
researchProduct

Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.

1995

Interferon alpha-2a (IFN-alpha) and folinic acid (FA) have been shown to modulate the cytotoxic effects of 5-fluorouracil (5-FU) in the treatment of cancer. A phase II study was initiated to evaluate the effect of a combination of 5-FU/FA/IFN-alpha in patients with advanced pancreatic cancer. Sixty previously untreated patients with advanced adenocarcinoma of the pancreas were treated with 500 mg m-2 FU via an intravenous bolus 1 h after the initiation of a 2 h infusion of 500 mg m-2 FA. Before starting the FA infusion, 6 million units (MU) of IFN-alpha was administered subcutaneously. The treatment was repeated once a week. Of 57 evaluable patients, eight (14%) had a partial response (PR),…

AdultMaleCancer Researchmedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentLeucovorinAlpha interferonAdenocarcinomaInterferon alpha-2GastroenterologyFolinic acidInternal medicinePancreatic cancerAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansInterferon alfaAgedChemotherapybusiness.industryInterferon-alphaMiddle Agedmedicine.diseaseRecombinant ProteinsSurgeryPancreatic NeoplasmsOncologyFluorouracilFemaleFluorouracilbusinessProgressive diseasemedicine.drugResearch ArticleBritish Journal of Cancer
researchProduct

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin…

1998

We carried out an open, randomized, phase III, multicenter clinical trial to compare, in neo-adjuvant setting, the clinical response and toxicity of the combination chemotherapy cisplatin + 5-FU with the same combination plus s.c. recombinant interleukin-2 (rIL-2) in patients with advanced (stage III IV) head and neck squamous-cell carcinoma (HNSCC). Regimen A was the classical Al Sarraf treatment: 100 mg/m2 cisplatin i.v. on day 1 plus 1000 mg m(-2) day(-1) 5-FU on days 1-5 as a continuous infusion. Regimen B was the same as regimen A plus 4.5 MIU/day rIL-2 s.c. on days 8-12 and 15-19. Treatment was repeated every 3 weeks for three cycles. A total of 33 patients were enrolled in the study;…

AdultMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentImmunologyAntineoplastic AgentsGastroenterologyGroup Blaw.inventionRandomized controlled triallawInternal medicinemedicineHumansImmunology and AllergyAgedChemotherapybusiness.industryCombination chemotherapyMiddle Agedmedicine.diseaseRecombinant ProteinsSurgeryRegimenOncologyEpidermoid carcinomaHead and Neck NeoplasmsFluorouracilCarcinoma Squamous CellInterleukin-2Drug Therapy CombinationFemaleFluorouracilCisplatinbusinessProgressive diseasemedicine.drugCancer Immunology, Immunotherapy
researchProduct